Aoife Brennan, M.B. Ch.B., President and Chief Executive Officer, participated in a fireside chat at 2:30 pm EST and in a panel discussion at 3:15 pm EST on Tuesday, March 1, 2022. The panel discussion was entitled “Great Debate – Is the Term ‘Microbiome’ Drug Development Now Passé?’, and both programs were held virtually.